Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFFWD.L Regulatory News (FFWD)

  • There is currently no data for FFWD

Acquisition

17 Oct 2006 07:00

London Asia Chinese Private Equity17 October 2006 17 October 2006 London Asia Chinese Private Equity Fund Limited ("LACPEF" or "the Fund") Investment in Chinese Solar Business LACPEF, the China focused investment fund, is pleased to announce that it isinvesting £2.1 million in China Solar Energy Co., Ltd. ("China Solar" or "theCompany") a leading constructor of solar energy buildings in China. The fundswill provide working capital for the construction of a number of newmulti-functional solar energy buildings, for which contracts were signed inSeptember. China Solar's core business is the design and manufacture of solar energybuildings in China, based on its patented solar thermal technology. The Companyhas been formed from the acquisition of the assets, intellectual property andwork in progress of Tianpu Solar, a Chinese company. In 2004, Tianpu Solarcompleted the first large scale building in China that uses solar power as thesole source of thermal energy - because of its ground-breaking design andapplication of technology, the building is used as a "Demonstration Building"for the 2008 Beijing Olympics. China has an increasing demand for fuel due to its rapid economic growth. Itselectricity supply is mainly based on coal. The use of renewable and alternativeenergy sources is becoming increasingly important as the Government seeks tofind alternatives to fossil fuels. The Company is currently completing a large scale leisure project in Beijing,believed to be one of the largest solar thermal buildings in the world, whichintegrates a range of sea themed leisure activities, including an aquarium, fishbreeding centre, floating tanks and restaurants, in one complex. The watertemperature, as well as all heating and cooling, is provided and regulated usingthe Company's patented solar technology. The Company has also developed an efficient, solar thermal heated and cooledhouse, designed to meet the requirements of the Chinese Governments' program forproviding affordable, energy efficient housing to the rural population, whichmakes up around 600 million of China's population. Mr Li Xianhang, founder and Chairman of China Solar, said: "Following the verysuccessful development of the leisure complex in Beijing, we have signed anumber of similar large projects in other parts of China for which we requireadditional capital, which the Fund is providing." Simon Littlewood, Executive Director of LACPEF, commented: "The Company haspatented technology, an experienced management team, a strong research anddevelopment programme, and strong support from the Chinese Government. Thereare significant opportunities for the Company to expand rapidly to takeadvantage of its strong brand and first-mover advantage, and the increasingemphasis by the Chinese Government on renewable energy sources and improving thequality of life for the poor." For further information please visit www.londonasiafunds.com or contact: John West/Matt Ridsdale Simon Littlewood Hugh FieldTavistock Communications London Asia Capital plc Collins Stewart LimitedTel: 020 7920 3150 Tel 020 7355 7928 Tel: 020 7523 8000 Notes on China Solar Energy The Company designs and constructs large scale municipal, commercial, academicand leisure buildings on a Build, Own, Transfer (BOT) basis, incorporating itsown patented solar thermal technology. Its key customers include the ChineseGovernment, real estate developers and resort owners. China Solar Energy Ltd isa Jersey incorporated holding company with a Chinese operating businessheadquartered in Beijing. For further information, visit http://en.tianpuxianxing.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
25th Feb 20207:00 amRNSInvestee Company Update: EMMAC Life Sciences
18th Feb 20207:00 amRNSInvestee Company Update: EMMAC Life Sciences
11th Feb 20207:00 amRNSUpdated Key Information Document
31st Jan 20201:30 pmRNSInvestee Company Update: Portage Biotech Inc.
8th Jan 20207:00 amRNSDisposal of Interest in Cryptologic Corp
7th Jan 20207:00 amRNSBoard Appointment
3rd Jan 20201:15 pmRNSInvestee Company Update: Portage Biotech Inc.
11th Dec 20197:00 amRNSHalf-year Report
5th Dec 20192:45 pmRNSTR-1 Notification
19th Nov 20197:00 amRNSLorne Abony appointed as Chairman of EMMAC
16th Oct 20197:00 amRNSInvestee Company Update: EMMAC Life Sciences
15th Oct 20197:00 amRNSInvestee Company Update: Factom inc.
10th Oct 20199:25 amRNSResult of 2019 AGM
27th Sep 20194:31 pmRNSDirector Dealing in the Company
27th Sep 20197:00 amRNSInvestee Company Update : Fralis LLC (Leap Gaming)
26th Sep 201911:21 amRNSInvestee Company Update : Cryptologic Corp
16th Sep 201911:52 amRNSTR-1 Notification of major holdings
11th Sep 20198:00 amRNSResults for the year ended 31st March 2019
11th Sep 20198:00 amRNSNotice of 2019 Annual General Meeting
22nd Aug 201912:01 pmRNSDirectorate Change
19th Aug 20199:23 amRNSJuvenescence closes Series B funding
12th Aug 20193:02 pmRNSInvestee Company Update-Cryptologic issues loan
12th Aug 201910:11 amRNSPortage Trading Suspended
6th Aug 20194:42 pmRNSInvestee Company Update: Cryptologic Corp
30th Jul 201911:07 amRNSSAFE Agreement with Factom, Inc. Extended
25th Jul 20198:17 amRNSFactom Inc SAFE Agreement temporary extension
18th Jul 201911:20 amRNSInvestee Company Update: Regent Pacific on Yooya
16th Jul 20199:13 amRNSInvestee Company Update:EMMAC acquires Terre Verde
11th Jul 20193:00 pmRNSDisposal of interest in Intensity Therapeutics Inc
9th Jul 201910:51 amRNSInvestee Company Update: EMMAC enters new Market
26th Jun 20198:56 amRNSInvestee Company Update: Intensity Therapeutics
29th May 20193:43 pmRNSInvestee Company Update: Offer for Yooya
13th May 201910:21 amRNSDisposal of interest in Vemo Education Inc.
18th Apr 20197:00 amRNSInvestee Company Update: Intensity Therapeutics
4th Apr 20199:51 amRNSTR1 - Correction
3rd Apr 20194:00 pmRNSTR:1 Regent Mercantile Holdings Limited
20th Mar 201911:00 amRNSCompletion of £2 million investment in EMMAC
7th Mar 20194:03 pmRNS£2 million investment in EMMAC Life Sciences
15th Jan 20193:45 pmRNSJuvenescence Series B Funding
3rd Jan 201911:47 amRNSBoard Appointment
12th Dec 201812:52 pmRNSHalf-year Report
3rd Dec 20187:00 amRNSInvestee Company Update: Factom and Yooya
14th Nov 20181:31 pmRNSInvestee Company Update: Factom Inc
22nd Oct 201812:24 pmRNSIntensity Therapeutics Inc Update
12th Sep 20186:12 pmRNSResult of AGM
10th Sep 20189:16 amRNSHolding(s) in Company
22nd Aug 20188:08 amRNSDirector Dealing
3rd Aug 201812:48 pmRNSShareholder update
3rd Aug 20188:00 amRNSPlacing
1st Aug 201812:05 pmRNSResponse to Media Speculation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.